Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions

The development of novel therapies against melanoma would benefit from individualized tumor models to ensure the rapid and accurate identification of biomarkers of therapy response. Previous studies have suggested that patient-derived xenografts (PDXes) could be useful. However, the utility of PDXes...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Einarsdottir, Berglind O., Bagge, Roger Olofsson, Bhadury, Joydeep, Jespersen, Henrik, Mattsson, Jan, Nilsson, Lisa M., Truvé, Katarina, López, Marcela Dávila, Naredi, Peter, Nilsson, Ola, Stierner, Ulrika, Ny, Lars, Nilsson, Jonas A.
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2014
נושאים:
Clinical Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259423/
https://ncbi.nlm.nih.gov/pubmed/25228592
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים